Skip to main content
editor@theusajournals.com | Oscar Publishing Services Journal Home
Login

American Journal Of Biomedical Science & Pharmaceutical Innovation

Peer Reviewed | Open Access | E-ISSN: 2771-2753
Published Article

Association Of Toll-Like Receptor 2 With Cytokines And Disease Activity In Rheumatoid Arthritis

Association Of Toll-Like Receptor 2 With Cytokines And Disease Activity In Rheumatoid Arthritis

Authors

  • Sibirkina Marina Valerevna
    PhD, associate professor Tashkent State Medical University, Tashkent, Uzbekistan
  • Eshmurzaeva Aida Abdiganievna
    D.M.Sc, professor Tashkent State Medical University, Tashkent, Uzbekistan
  • Mirzayeva Shakhnoza Khamidjonovna
    Phd, assistant Tashkent State Medical University, Tashkent, Uzbekistan
  • Isroilov Azizjon G‘ayrat o‘g‘li
    student Tashkent State Medical University, Tashkent, Uzbekistan

DOI:

https://doi.org/10.37547/ajbspi/Volume06Issue05-09

Keywords:

Rheumatoid arthritis TLR2 IL-1 IL-6

Abstract

This research aimed to determine the link between Toll-like receptors (TLR) 2, cytokines that promote inflammation, and the clinical state of patients with rheumatoid arthritis (RA). TLR2 levels were studied in conjunction with serum levels of the inflammatory cytokines IL-1, IL-6, and TNF-α, along with vitamin D, C reactive protein (CRP), rheumatoid factor (RF), anti-citrullinated protein antibodies (anti CCP's), and disease activity scores (DAS-28) on both articular and extra-articular RA patients. Those with extra-articular features had a much greater statistically significant correlation of TLR2 and pro-inflammatory cytokines than those with only articular features. TLR2 levels were also found to have a statistically significant association with DAS28 values and the presence of anti-CCP positivity. These results suggest that TLR2 may be used as a prognostic indicator for both immune and inflammatory activity in RA.

References

Brennan, F. M., & McInnes, I. B. (2008). Evidence that cytokines play a role in rheumatoid arthritis. The Journal of Clinical Investigation, 118(11), 3537–3545. https://doi.org/10.1172/JCI36389

Kawai, T., & Akira, S. (2011). Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity, 34(5), 637–650. https://doi.org/10.1016/j.immuni.2011.05.006

Nishimura, K., Sugiyama, D., Kogata, Y., Tsuji, G., Nakazawa, T., Kawano, S., et al. (2007). Meta-analysis: Diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Annals of Internal Medicine, 146(11), 797–808. https://doi.org/10.7326/0003-4819-146-11-200706050-00008

O’Neill, L. A., Golenbock, D., & Bowie, A. G. (2013). The history of Toll-like receptors — redefining innate immunity. Nature Reviews Immunology, 13(6), 453–460. https://doi.org/10.1038/nri3446

Scott, D. L., Wolfe, F., & Huizinga, T. W. (2010). Rheumatoid arthritis. The Lancet, 376(9746), 1094–1108. https://doi.org/10.1016/S0140-6736(10)60826-4

Song, G. G., Bae, S. C., & Lee, Y. H. (2012). Association between vitamin D intake and the risk of rheumatoid arthritis: A meta-analysis. Clinical Rheumatology, 31(12), 1733–1739. https://doi.org/10.1007/s10067-012-2080-7